Lung Cancer Clinical Trial
Tele-Navigation of Lung Cancer Screening (Tele-Navi LCS)
Summary
Adherence to annual follow up is critical to achieving mortality benefits and optimizing cost-effectiveness of lung cancer screening (LCS). However, adherence to LCS follow-up in the real world is suboptimal. Using telehealth, the investigators will co-create Tele-Navigation of Lung Cancer Screening with patients and LCS stakeholders as an intervention to promote adherence of follow-up LCS. The investigators will then implement the Tele-Navi LCS intervention to a pilot sample of patients and evaluate its feasibility in the primary care setting. The investigators will measure the number of patient participants who completed Tele-Navi LCS and follow-up LCS within 180 days from Tele-Navi LCS.
Eligibility Criteria
Inclusion Criteria:
Is eligible for LDCT for LCS follow-up
Has technology to complete study activities (e.g., video call visit)
English speaker
Has undergone LCS at UMMH
Is overdue for LDCT follow-up
Exclusion Criteria:
Has previous diagnosis of lung cancer
Has active cancer diagnosis
Is a nursing home or group care resident
Is pregnant
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Worcester Massachusetts, 01655, United States
How clear is this clinincal trial information?